Association of glucagon-like peptide-1 receptor agonist vs dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced chronic kidney disease
Conservative protocols, very those using higher doses or in subjects where safety is a main concern, may prefer shorter cycles to limit exposure duration
Biological consequences of zinc deficiency in the pathomechanisms of selected diseases
Brain natriuretic peptide (BNP) and delta sleep inducing peptide are entirely different molecules
Mitochondria, Cholesterol, and the State of Abundance CHRIS MASTERJOHN: Well, yeah, I think this is a great tie back to the things we were talking about before, because the clearance of cholesterol from your blood is driven by the mitochondrial energy production that gives your brain the signal that you are in a state of abundance and should put that cholesterol toward good things
This could lead to reduced demand for snacks, sweets, sugary beverages, and other foods commonly associated with indulgence and comfort eating. Shift in Consumer Preferences As users of GLP-1 medications experience less hunger and eat smaller portions, they may shift towards more nutrient-dense foods that offer better satiety per calorie, like protein-rich foods, fruits, and vegetables